1 / 7

Inhalation Anesthesia Market share to reach $1.6bn by 2024

Get more details @ http://bit.ly/2eEa96c <br>Some of the prominent players in inhalation anesthesia market are Baxter International, Hikma Pharmaceuticals, Mylan, Eisai, Halocarbon Products, Abbott, Piramal and Lunan Pharmaceutical.

jueekate
Download Presentation

Inhalation Anesthesia Market share to reach $1.6bn by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Inhalation Anesthesia Market to grow at 3.5% CAGR from 2016 to 2024 :Global Market Insights Inc.

  2. Key Insights from Inhalation AnesthesiaMarket : • Global Market Insights, Inc. says, Inhalation Anesthesia Market size is set to exceed USD 1.6 billion by 2024. • Rising number of geriatric population coupled with increasing number of chronic diseases such as cancer, cardiovascular, neurological, and respiratory disorders and introduction of advanced anesthesia will offer lucrative growth opportunities for the inhalation anesthesia market growth. • Increasing number of emergency surgeries driving the count of hospital admissions coupled with favorable private and public insurance will drive the inhalation anesthesia market. • Adverse side effects during recovery, procedure or surgery, or wearing off anesthesia coupled with effect like intraoperative discomfort, hypotension, post-lumbar-puncture headache, and potential for neurologic and cardiac toxicity from anesthetics may hamper the inhalation anesthesia market growth.

  3. Continued... • Sevoflurane segment accounted for the highest revenue share in 2016 and will grow at a significant rate over the forecast period owing to growing use in both maintenance and induction. • U.S. market was valued over USD 488 million in 2016 and will grow significantly over the coming years. • Germany accounted for highest revenue share in the region, owing to increasing chronic conditions associated with elderly population coupled with adoption rate of inhalation anesthesia. • Some of the companies operating in market are Abbott, Baxter International, Piramal, Lunan Pharmaceutical, Hikma Pharmaceuticals and Halocarbon Products.

  4. U.S. Inhalation Anesthesia Market, By Product, 2013 - 2024 (USD Million)

  5. Browse Full Market Research Report On Inhalation AnesthesiaMarket @ http://bit.ly/2egy4pA Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/704https://www.gminsights.com/request-sample/detail/49

  6. 360° Analysis • Product Analysis • Sevoflurane dominated inhalation anesthesia market in 2016. The growth is attributed to high preference for sevoflurane and suitable for children and adults for maintenance as well as induction. Moreover, associated characteristics such as, low flammability, dearth of annoyance to airway passages, intrinsic stability. • Regional Analysis • U.S. inhalation anesthesia market accounted for largest regional share in 2016. Increasing number of plastic surgeries along with rising prevalence of chronic lower respiratory disease will fuel adoption of inhalation anesthesia. • Competitive Market Share • Some of the prominent players in inhalation anesthesia market are Baxter International, Hikma Pharmaceuticals, Mylan, Eisai, Halocarbon Products, Abbott, Piramal and Lunan Pharmaceutical.

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related